Advertisement

Topics

TEVA Pharmaceuticals-Aktie hat noch Potenzial! - Aktienanalyse

10:34 EDT 30 Aug 2017 | FinanzNachrichten

New York - TEVA Pharmaceuticals-Aktienanalyse von Analyst Jami Rubin von Goldman Sachs: Der Aktienanalyst Jami Rubin von der Investmentbank Goldman Sachs rechnet bei den Aktien des Pharmakonzerns T...

Original Article: TEVA Pharmaceuticals-Aktie hat noch Potenzial! - Aktienanalyse

NEXT ARTICLE

More From BioPortfolio on "TEVA Pharmaceuticals-Aktie hat noch Potenzial! - Aktienanalyse"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...